Ventricular pacing in atypical ventricular tachycardia

Area of Science:

• Cardiology
• Electrophysiology
• Pharmacology

Background:

• Recurrent atypical ventricular tachycardia, specifically Torsade de Pointes (TdP), can be a life-threatening arrhythmia.
• Drug-induced Torsade de Pointes, often associated with quinidine or disopyramide, poses a significant clinical challenge.
• Isoproterenol is the conventional treatment but may be ineffective or contraindicated in some cases.

Observation:

• Four patients experiencing recurrent Torsade de Pointes induced by quinidine or disopyramide were studied.
• Standard isoproterenol therapy was found to be ineffective in two patients and potentially hazardous in two others.
• Ventricular pacing was implemented as an alternative therapeutic strategy.

Findings:

• Ventricular pacing demonstrated effectiveness in controlling recurrent episodes of drug-induced Torsade de Pointes across all four patients.
• The study highlights successful management of Torsade de Pointes through ventricular pacing when conventional therapy failed or posed risks.

Implications:

• Ventricular pacing represents a safe and reliable therapeutic option for managing atypical ventricular tachycardia, particularly Torsade de Pointes.
• This approach should be considered when isoproterenol is not a viable treatment due to inefficacy or contraindications.
• The findings support the integration of ventricular pacing into treatment algorithms for refractory drug-induced Torsade de Pointes.